- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.10. | Iambic prices its IPO, seeking to raise up to $160m | ||
| 09.10. | Matchpoint scores $150m for I&I drugs, and other financings | ||
| 08.10. | argenx's Forte acquisition delivers coeliac trial win | ||
| 08.10. | Viatris builds in pain relief with $1.65bn Pacira purchase | ||
| 08.10. | Pfizer's Tukysa greenlit for earlier use in breast cancer | ||
| 08.10. | Chemistry Nobel goes to molecular chirality researchers | ||
| 08.10. | PhRMA sues Trump administration over GLOBE rebate scheme | ||
| 08.10. | Biohub raises $1.8bn for its 'virtual biology' initiative | ||
| 07.10. | Rhapsido is first drug cleared for chronic hives disorder SD | ||
| 07.10. | MSD ordered to pull injectable Keytruda from sale in Europe | ||
| 07.10. | European biotech leaders say optimism is returning | ||
| 07.10. | UK watchdog takes first action on oral weight drug adverts | ||
| 07.10. | Adecto, Aviceda wind down, as Caribou seeks options | ||
| 07.10. | ViiV's Cabenuva enhances control of unsuppressed HIV | ||
| 06.10. | Click claims FDA okay for first-in-class schizophrenia DTx | ||
| 06.10. | AstraZeneca cuts ribbon on new R&D facility in Massachusetts | ||
| 06.10. | UK backs all health AI proposals in commission report | ||
| 06.10. | New York declares measles outbreak a "disaster emergency" | ||
| 05.10. | Vaxcyte's pneumococcal jab exceeds expectations | ||
| 05.10. | Lilly's BTK drug Jaypirca joins first-line options in US | ||
| 05.10. | Nobel Prize in Medicine awarded to optogenetics trio | ||
| 05.10. | Shionogi's diversification continues with $2bn IntraBio buy | ||
| 05.10. | Novo faces delay in US review of haemophilia drug | ||
| 05.10. | CSL joins forces with Alentis on claudin candidate | ||
| 02.10. | Novartis taps China's Abogen for autoimmunity TCE |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.